Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Norgestimate and Ethinyl Estradiol Tablets USP, 0.25 mg/0.035 mg
Medication labelWhy this: Advisory · dailymed-prescription
Norgestimate and ethinyl estradiol tablets USP are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Oral contraceptives are highly effective for pregnancy prevention. Table II lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, the IUD, and the Norplant System, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates. Norgestimate and ethinyl estradiol tablets USP have not been studied for and are not indicated for use in emergency contraception. In clinical trials with norgestimate and ethinyl estradiol tablets, 1,651 subjects completed 24,272 cycles and the overall use-efficacy (typical user efficacy) pregnancy rate was approximately 1 pregnancy per 100 women-years. This rate includes patients who did not take the drug correctly.
- generic_name
- norgestimate and ethinyl estradiol
- brand_name
- inert
- product_names
- Norgestimate and Ethinyl Estradiol, inert
- ndc
- 68462-309, 68462-309-84, 68462-309-29
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en